Evidence map›Paper›PMID 41469815›Full record

ArticleCancer medicine2026

Histopathology Images-Based Deep Learning Prediction of Histological Types in Endometrial Cancer.

Lingmei Li, Pengbo Wang, Changyu Geng, Jingyi Wang, Lu Cao, Yanan Gao, Dandan Chen, Ge Qiao, Shi Zhang, Ningrui Feng and 9 more

Abstract read
In one paragraph

Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Lingmei LiDepartment of Pathology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, China.
Pengbo WangDepartment of Breast Imaging, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, China.
Changyu GengDepartment of Pathology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, China.
Jingyi WangDepartment of Pathology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, China.
Lu CaoDepartment of Pathology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, China.
Yanan GaoDepartment of Pathology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, China.
Dandan ChenDepartment of Pathology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, China.
Ge QiaoDepartment of Pathology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, China.
Shi ZhangDepartment of Pathology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, China.
Ningrui FengDepartment of Pathology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, China.
Ming LiuDepartment of Pathology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, China.
Xiaofeng LiDepartment of Molecular Imaging and Nuclear Medicine, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, China.
Yaomei MaDepartment of Gynecology Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Su ZhangDepartment of Gynecology Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Huiting XiaoDepartment of Gynecology Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Zhongmin JiangDepartment of Pathology, Tianjin Fifth Central Hospital Tianjin, Tianjin, China.
Xiaozhi LiuTianjin Key Laboratory of Epigenetic for Organ Development of Preterm Infants, Tianjin Fifth Central Hospital, Tianjin, China.
Wenjuan MaDepartment of Breast Imaging, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, China.
Lisha QiDepartment of Pathology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, China.ORCID https://orcid.org/0000-0002-8700-4690

Funding

National Natural Science Foundation of China 81700103National Natural Science Foundation of China 82002813National Natural Science Foundation of China 82072004National Natural Science Foundation of China 82202909National Natural Science Foundation of China 82272074The Science & Technology Development Fund of Tianjin Education Commission for Higher Education 2021KJ193Tianjin Health Technology Project TJWJ2023MS053Tianjin Key Medical Discipline Construction Project TJYXZDXK-3-016CTianjin Municipal Science and Technology Program 24ZYCGSY00650
6 · The paper itself

Abstract

backgroundAccording to the new 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer (EC), EC is classified into aggressive and nonaggressive histological types. Accurate diagnosis of the histological type of EC is crucial for optimizing treatment strategies and predicting patient outcomes.

objectivesTo develop and validate a deep convolutional neural network for predicting nonaggressive versus aggressive histological types from hematoxylin and eosin (H&E)-stained images of EC specimens.

methodsA deep convolutional neural network named EC-AI

resultsEC-AI

conclusionsEC-AI

Indexed as

Deep LearningEndometrial NeoplasmsFemaleHumansMiddle AgedNeural Networks, Computer2023 International Federation of Gynecology and Obstetrics stagingdeep learningendometrial cancerhistological types

Identifiers

PMID41469815
PMCPMC12753328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.